PCG
93
4
GT
58
4
PPG
68
4
MAC
51
4
ETR
60
2
EFX
61
3
SIG
72
2
FCX
52
-4
RRC
65
3
FLR
59
4
AIV
64
6
SWK
64
-13
PBI
49
10
BRK.B
49
2
BSX
69
-2
FTI
84
3
UNH
56
4
SE
52
2
ZION
55
3
URI
60
2
PCG
93
4
GT
58
4
PPG
68
4
MAC
51
4
ETR
60
2
EFX
61
3
SIG
72
2
FCX
52
-4
RRC
65
3
FLR
59
4
AIV
64
6
SWK
64
-13
PBI
49
10
BRK.B
49
2
BSX
69
-2
FTI
84
3
UNH
56
4
SE
52
2
ZION
55
3
URI
60
2
Financhill
Back

Galmed Pharmaceuticals 10K Form

Sell
40

GLMD
Galmed Pharmaceuticals

Last Price:
0.40
Seasonality Move:
-4.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GLMD News And Ratings

See the #1 stock for the next 7 days that we like better than GLMD

GLMD Financial Statistics

Sales & Book Value

Annual Sales: $2.04M
Cash Flow: $-898K
Price / Cash Flow: 0
Annual Sales: $2.75
Price / Book: 0.17

Profitability

EPS (TTM): -3.26000
Net Income (TTM): $-6.91M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Galmed Pharmaceuticals Earnings Forecast

Key Galmed Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 4 years for GLMD is 0.00%.
  • The Selling, General & Administrative Expenses for GLMD have been equal to 217.86% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Galmed Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLMD
CUSIP: M47238
Website: galmedpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GLMD Technical Analysis vs Fundamental Analysis

Sell
40
Galmed Pharmaceuticals (GLMD) is a Sell

Is Galmed Pharmaceuticals a Buy or a Sell?